Condition: Ulcerative Colitis (UC) · Sponsor: University College Cork
This international multicentre prospective study aims to develop a new simple score using enhanced endoscopic techniques which focus on the vascular features of the colon and reliably distinguish between a quiescent and a mild inflammation in ulcerative colitis (UC). The diagnostic performance of the new score in defining disease activity/remission compared to existing endoscopic and histological scores and predict long-term clinical outcomes will be evaluated. The study also aims to adapt current artificial intelligence (AI) algorithms for enhanced endoscopic techniques to improve standardization in UC disease assessment and outcome prediction.
This description comes directly from the study's public registry record.
Michelle O'Riordan · +353 (0)21 4901759 · moriordan@ucc.ie
Always discuss trial participation with your own doctor first.
| University of Leuven | Leuven, Belgium | Not Yet Recruiting |
| Klinikum Luneburg | Lüneburg, Germany | Not Yet Recruiting |
| University College Cork | Cork, Co Cork, Ireland | Recruiting |
| Ospedale S. Maria del Prato | Feltre, Belluno, Italy | Not Yet Recruiting |
| University of Bari | Bari, Italy | Not Yet Recruiting |
| Istituto Clinico Humanitas | Milan, Italy | Not Yet Recruiting |
| University Vita-Salute San Raffaele | Milan, Italy | Not Yet Recruiting |
| University of Naples | Naples, Italy | Recruiting |
| University of Pavia | Pavia, Italy | Not Yet Recruiting |
| Showa University | Tokyo, Japan | Not Yet Recruiting |
| Changi General Hospital | Singapore, Singapore | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06709209